Kimberly Banks MacKay was appointed to CTS Corporation’s Board of Directors effective November 5, 2025, with the announcement released on November 6, 2025. She will serve on the Nominating, Governance and Sustainability Committee and the Technology and Transactions Committee, expanding the board’s oversight of corporate governance and strategic technology initiatives.
Ms. MacKay brings more than three decades of experience in multinational corporations. She most recently held the role of Senior Vice President, General Counsel and Corporate Secretary at West Pharmaceutical Services, Inc., and she also sits on the Board of the Community Foundation of New Jersey and serves on the Compliance, Audit and Risk Committee for BAYADA Home Health Care. Her legal acumen and deep familiarity with the healthcare sector position her to advise on regulatory compliance, risk management and emerging opportunities in medical markets.
CTS’s strategy to broaden its footprint in medical, industrial, aerospace and defense markets is reinforced by Ms. MacKay’s expertise. Her background in healthcare law and corporate governance aligns with the company’s goal of expanding in the medical arena while maintaining rigorous oversight and sustainability practices. The appointment signals CTS’s commitment to strengthening its governance framework and leveraging specialized knowledge to drive growth in high‑growth end markets.
The board now consists of eight directors, up from seven, reflecting CTS’s intent to broaden its governance perspective. CEO Kieran O’Sullivan noted that Ms. MacKay’s experience will be a “valuable addition” to the board, supporting the company’s focus on growth, end‑market diversification and products that sense, connect and move.
CTS also announced its third‑quarter 2025 earnings on the same day. The company reported a slight miss on earnings per share but exceeded revenue expectations, underscoring continued demand across its core segments while highlighting the need for disciplined cost management.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.